Evidence map›Paper›PMID 16172426›Full record

ArticleHypertension (Dallas, Tex. : 1979)2005

Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation.

Stephen J Duffy, Elizabeth S Biegelsen, Robert T Eberhardt, David F Kahn, Bronwyn A Kingwell, Joseph A Vita

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 58 citations in OpenAlex.

  1. Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2019
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Sex Differences and COVID-19.Advances in experimental medicine and biology · 2021
    Article
  7. Review
  8. Observational
  9. Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism.Hypertension research : official journal of the Japanese Society of Hypertension · 2018
    Article
  10. Article
  11. Article
  12. Renin-angiotensin-aldosterone system gender differences in an Afro-Caribbean population.Journal of the renin-angiotensin-aldosterone system : JRAAS · 2015
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Stephen J DuffyThe Heart Centre, Alfred Hospital and Baker Heart Research Institute, Melbourne, Victoria, Australia.
Elizabeth S Biegelsen
Robert T Eberhardt
David F Kahn
Bronwyn A Kingwell
Joseph A Vita
Baker Heart and Diabetes Institute · AU

Funding

YOGA INDUCED CHANGES IN BRAIN GABA LEVELSM01RR000533 · NCRR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HOLICK, MICHAEL F. · 1985 to 2008
$19.4M
SCOR IN ISCHEMIC HEART DISEASE IN BLACKSP50HL055993 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LOSCALZO, JOSEPH · 1995 to 2004
$6.9M
Vitamin C, glutathione and NO action in humansP01HL060886 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI VITA, JOSEPH A. · 2000 to 2004
$5.4M
NCRR NIH HHS M01 RR000533NCRR NIH HHS M01RR00533NHLBI NIH HHS HL55993NHLBI NIH HHS HL60886NHLBI NIH HHS P01 HL060886NHLBI NIH HHS P50 HL055993
6 · The paper itself

Abstract

Recent studies suggest that hypertension associated with low renin status and hyperaldosteronism is associated with increased risk for end-organ damage and cardiovascular events compared with other forms of hypertension. Additionally, experimental studies have demonstrated impaired nitric oxide-mediated bioactivity in these states. To investigate the relation between renin/aldosterone status and resistance vessel function, we examined plasma renin activity, serum aldosterone level, and forearm blood flow responses to the endothelium-dependent vasodilator methacholine and the endothelium-independent vasodilators sodium nitroprusside and verapamil using venous occlusion plethysmography in 130 volunteers (43 hypertensive, 87 normotensive). Low renin status was associated with impaired responses to methacholine and nitroprusside in patients with hypertension. Peak methacholine response was 8.7+/-5.6 mL/min per dL in the lowest renin quartile (0.1 to 0.3 ng/mL per hour) versus 14.3+/-7.3 mL/min per dL in the highest 3 renin quartiles combined (0.4 to 4.6 ng/mL per hour; P<0.001). Peak nitroprusside response was 5.6+/-2.3 mL/min per dL in the lowest renin quartile versus 13.3+/-4.1 mL/min per dL in the highest 3 renin quartiles combined (P<0.001). Blood pressure and other clinical characteristics were similar in all 4 quartiles. Vasodilator responses to verapamil did not relate to renin activity. Methacholine and nitroprusside responses did not relate to renin status in normotensive controls (P=0.34). Importantly, hypertensive patients with a high aldosterone/renin ratio also had impaired responses to methacholine. This study demonstrates that low-renin hypertension is associated with marked impairment of nitric oxide-mediated vasodilation of resistance vessels in the forearm vasculature of humans. This impairment could contribute to adverse outcomes in patients with low-renin hypertension and relative aldosterone excess.

Indexed as

VasodilationAdultAgedAldosteroneCase-Control StudiesFemaleForearmHumansHyperaldosteronismHypertensionMaleMiddle AgedNitric OxideProspective StudiesReninVascular ResistanceAldosteroneNitric OxideRenin

Identifiers

PMID16172426
PMCPMC2737344
OpenAlexW2150931520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.